受强制性开放获取政策约束的文章 - Jean Jacques Vanden Eynde了解详情
无法在其他位置公开访问的文章：1 篇
Evaluation of bisbenzamidines as inhibitors for matriptase-2
AM Beckmann, E Gilberg, S Gattner, TL Huang, JJV Eynde, A Mayence, ...
Bioorganic & medicinal chemistry letters 26 (15), 3741-3745, 2016
强制性开放获取政策： US National Institutes of Health, German Research Foundation
可在其他位置公开访问的文章：18 篇
Novel bisbenzimidazoles with antileishmanial effectiveness
A Mayence, A Pietka, MS Collins, MT Cushion, BL Tekwani, TL Huang, ...
Bioorganic & medicinal chemistry letters 18 (8), 2658-2661, 2008
强制性开放获取政策： US National Institutes of Health
COVID-19: A Brief Overview of the Discovery Clinical Trial
JJ Vanden Eynde
Pharmaceuticals 13 (4), 65, 2020
强制性开放获取政策： Bill & Melinda Gates Foundation, National Institute of Health and Medical …
Synthesis and SAR of alkanediamide-linked bisbenzamidines with anti-trypanosomal and anti-pneumocystis activity
TL Huang, JJV Eynde, A Mayence, MS Collins, MT Cushion, D Rattendi, ...
Bioorganic & medicinal chemistry letters 19 (20), 5884-5886, 2009
强制性开放获取政策： US National Institutes of Health
Design and Synthesis of N1, N5-bis [4-(5-Alkyl-1, 2, 4-oxadiazol-3-yl) phenyl] glutaramides as Potential Antifungal Prodrugs
NR Kode, JJ Vanden Eynde, A Mayence, G Wang, TL Huang
Molecules 18 (9), 11250-11263, 2013
强制性开放获取政策： US National Institutes of Health
Pentamidine analogs as inhibitors of [3H] MK-801 and [3H] ifenprodil binding to rat brain NMDA receptors
ML Berger, D Maciejewska, JJV Eynde, M Mottamal, J Żabiński, ...
Bioorganic & medicinal chemistry 23 (15), 4489-4500, 2015
强制性开放获取政策： US National Institutes of Health
Biological evaluation of bisbenzaldehydes against four Mycobacterium species
D Cappoen, D Forge, F Vercammen, V Mathys, M Kiass, V Roupie, ...
European journal of medicinal chemistry 63, 731-738, 2013
强制性开放获取政策： Research Foundation (Flanders)
Dual-target inhibitors of the folate pathway inhibit intrinsically trimethoprim-resistant DfrB dihydrofolate reductases
JL Toulouse, G Shi, C Lemay-St-Denis, MC Ebert, D Deon, M Gagnon, ...
ACS Medicinal Chemistry Letters 11 (11), 2261-2267, 2020
强制性开放获取政策： US National Institutes of Health, Natural Sciences and Engineering Research …
Structure-Based Design of Dimeric Bisbenzimidazole Inhibitors to an Emergent Trimethoprim-Resistant Type II Dihydrofolate Reductase Guides the Design of Monomeric Analogues
JL Toulouse, BJ Yachnin, EH Ruediger, D Deon, M Gagnon, ...
ACS Omega 4 (6), 10056-10069, 2019
强制性开放获取政策： Canadian Institutes of Health Research, Natural Sciences and Engineering …
Designing a high performance, stable spectroscopic biosensor for the binding of large and small molecules
E Gosselin, JJV Eynde, A Petit, J Conti, J De Coninck
Journal of colloid and interface science 508, 443-454, 2017
强制性开放获取政策： National Fund for Scientific Research, Belgium
COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now–New Hopes?
JJ Vanden Eynde
Pharmaceuticals 14 (7), 664, 2021
强制性开放获取政策： National Institute of Health and Medical Research, France
Bioactive Aliphatic Polycarbonates Carrying Guanidinium Functions: An Innovative Approach for Myotonic Dystrophy Type 1 Therapy
A Baroni, I Neaga, N Delbosc, M Wells, L Verdy, E Ansseau, ...
ACS omega 4 (19), 18126-18135, 2019
强制性开放获取政策： National Fund for Scientific Research, Belgium
Alkanediamide-Linked Bisbenzamidines Are Promising Antiparasitic Agents
JJ Vanden Eynde, A Mayence, M Mottamal, CJ Bacchi, N Yarlett, M Kaiser, ...
Pharmaceuticals 9 (2), 20, 2016
强制性开放获取政策： US National Institutes of Health
Ultra high performance liquid chromatography method for the determination of pentamidine and analog in rat biological fluids
S Hambye, M Helvenstein, L Verdy, Z Kahvecioglu, R Conotte, JJV Eynde, ...
Journal of pharmaceutical and biomedical analysis 95, 54-60, 2014
强制性开放获取政策： National Fund for Scientific Research, Belgium
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–7
M Gütschow, JJ Vanden Eynde, J Jampilek, CB Kang, AA Mangoni, ...
Molecules 25 (13), 2968, 2020
强制性开放获取政策： US National Institutes of Health
Second International Electronic Conference on Medicinal Chemistry (ECMC-2)
A Mayence, JJV Eynde
Pharmaceuticals 10 (1), 20, 2017
强制性开放获取政策： Austrian Science Fund, Fundação para a Ciência e a Tecnologia, Portugal
First International Electronic Conference on Medicinal Chemistry (ECMC-1)
A Mayence, JJ Vanden Eynde
Pharmaceuticals 9 (1), 14, 2016
强制性开放获取政策： Irish Research Council
Characterization of the symmetrical benzimidazole twin drug TL1228: the role as viral entry inhibitor for fighting COVID-19
M Murdocca, O Andrade Santos-Filho, C De Masi, ...
Biology Direct 19 (1), 1-14, 2024
强制性开放获取政策： European Commission
Third International Electronic Conference on Medicinal Chemistry (ECMC-3)
A Mayence, JJV Eynde
Pharmaceuticals 11 (1), 18, 2018
强制性开放获取政策： Government of Spain
出版信息和资助信息由计算机程序自动确定